Get all office locations for this firm with a National Database subscription.

 

Stages:

• Early
• Expansion
• Growth
• Seed

 

Industries:

Life Sciences & Healthcare

Medical Device

 

Description:

SV Health Investors (formerly SV Life Sciences) is a leading international life sciences venture capital firm. SV affiliated funds have been investing in life sciences companies since the early 1980s and the firm closed its first dedicated life sciences fund in 1994. The SV team manages five private venture capital funds with approximately $2.0 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health-care services. SVL has offices in Boston and London. SV was started in London as Schroder Ventures Life Sciences in 1993 as part of the Schroder Ventures Group. SVLS became independent of the Schroder Ventures Group in 2001, and in January 2005 changed its name to SV Life Sciences to reflect independent ownership. The firm usually commits $1 to $40 million per company, diversifying its portfolio by sub sector, geography and stage of company. SVLSFV has total commitments of $3b (plus $11 million of co-investments committed by partners and individuals affiliated with SVLS). As of September 2011 the Fund had invested $78m in 19 portfolio companies.

 

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.